Indeed, administration of Liraglutide (Fig. EV1O–P) also very significantly decreased the number of both Ki67+ cells both in the MBH and the ME, suggesting that different anti-obesity compounds exert similar effects on hypothalamic proliferation in the context of HFD. The gene discussed is MKI67; the disease is obesity due to melanocortin 4 receptor deficiency.